Načítá se...
Vitamin D treatment modulates immune activation in cystic fibrosis
Persistent inflammatory response in cystic fibrosis (CF) airways is believed to play a central role in the progression of lung damage. Anti‐inflammatory treatment may slow lung disease progression, but adverse side effects have limited its use. Vitamin D has immunoregulatory properties. We randomize...
Uloženo v:
| Vydáno v: | Clin Exp Immunol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5543500/ https://ncbi.nlm.nih.gov/pubmed/28470739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12984 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|